Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection.
Saved in:
| Title: | Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection. |
|---|---|
| Authors: | Yin X; State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China., Pu Y; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Yuan S; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Pache L; NCI Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, United States of America., Churas C; Department of Medicine, University of California San Diego, La Jolla, California, United States of America., Weston S; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Riva L; Calibr-Skaggs at Scripps Research Institute, La Jolla, California, United States of America., Simons LM; Division of Infectious Diseases, Departments of Medicine and Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America., Cisneros WJ; Division of Infectious Diseases, Departments of Medicine and Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America., Clausen T; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, United States of America., Biddle G; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Doss-Gollin S; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Deming M; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., De Jesus PD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Kim HN; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia., Fuentes D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Whitelock JM; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia., Esko JD; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, United States of America., Lord MS; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia., Mena I; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; The Tisch Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.; The Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America., Hultquist JF; Division of Infectious Diseases, Departments of Medicine and Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America., Frieman MB; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Ideker T; Department of Medicine, University of California San Diego, La Jolla, California, United States of America.; Department of Computer Science and Engineering, University of California San Diego, La Jolla, California, United States of America., Pratt D; Department of Medicine, University of California San Diego, La Jolla, California, United States of America., Martin-Sancho L; Department of Infectious Disease, Imperial College London, London, United Kingdom., Chanda SK; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Calibr-Skaggs at Scripps Research Institute, La Jolla, California, United States of America. |
| Source: | PLoS biology [PLoS Biol] 2025 Jun 12; Vol. 23 (6), pp. e3002738. Date of Electronic Publication: 2025 Jun 12 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1545-7885 |
|---|---|
| DOI: | 10.1371/journal.pbio.3002738 |
